Search hospitals > Ohio > Columbus
Columbus Oncology and Hematology Associates Inc
Claim this profileColumbus, Ohio 43214
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
221 reported clinical trials
8 medical researchers
Summary
Columbus Oncology and Hematology Associates Inc is a medical facility located in Columbus, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Columbus Oncology and Hematology Associates Inc is involved with conducting 221 clinical trials across 384 conditions. There are 8 research doctors associated with this hospital, such as Timothy D. Moore, Aine E. Clements, Anitha S. Nallari, and Chaoyang Li.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Timothy D. MooreThe Mark H Zangmeister Center4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
126 reported clinical trials
208 drugs studied
Aine E. ClementsOhioHealth Mansfield Hospital7 years of reported clinical research
Studies Ovarian Cancer
Studies Cancer
6 reported clinical trials
31 drugs studied
Anitha S. NallariColumbus Oncology and Hematology Associates9 years of reported clinical research
Studies Cancer
Studies Renal Cell Carcinoma
3 reported clinical trials
6 drugs studied
Chaoyang LiDelaware Health Center-Grady Cancer Center8 years of reported clinical research
Studies Skin Cancer
Studies Melanoma
2 reported clinical trials
8 drugs studied
Clinical Trials running at Columbus Oncology and Hematology Associates Inc
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Bladder Carcinoma
Melanoma
Cutaneous Melanoma
Ovarian Cancer
Bladder Cancer
Multiple Myeloma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Columbus Oncology and Hematology Associates Inc?
Columbus Oncology and Hematology Associates Inc is a medical facility located in Columbus, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Columbus Oncology and Hematology Associates Inc is involved with conducting 221 clinical trials across 384 conditions. There are 8 research doctors associated with this hospital, such as Timothy D. Moore, Aine E. Clements, Anitha S. Nallari, and Chaoyang Li.